Synaptogenix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Synaptogenix and other ETFs, options, and stocks.About SNPX
Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of Bryostatin and Platform Drug used for the treatment of Alzheimer’s disease, Fragile X Syndrome or Autism, Multiple Sclerosis, Parkinson’s Disease, Traumatic Brain Injury, and Stroke. The company was founded on October 31, 2012 and is headquartered in New York, NY.
CEOAlan J. Tuchman
CEOAlan J. Tuchman
Employees6
Employees6
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2012
Founded2012
Employees6
Employees6
SNPX Key Statistics
Market cap3.39M
Market cap3.39M
Price-Earnings ratio-0.24
Price-Earnings ratio-0.24
Dividend yield—
Dividend yield—
Average volume4.43K
Average volume4.43K
High today$2.44
High today$2.44
Low today$2.33
Low today$2.33
Open price$2.39
Open price$2.39
Volume5.86K
Volume5.86K
52 Week high$5.38
52 Week high$5.38
52 Week low$1.84
52 Week low$1.84